Muna Therapeutics

📍 København N, Denmark🗓 Founded 2020👥 44 employees💰 Last funded Jul 2021
Biotechnology Research🌐 munatherapeutics.com
Website LinkedIn
Muna Therapeutics is a privately held biopharmaceutical company founded in 2020 and based in Copenhagen, Denmark. Muna discovers and develops therapies that slow or stop devastating neurodegenerative diseases including Alzheimer’s, Frontotemporal Dementia and Parkinson’s. These disorders impact memory, movement, language, behavior and personality resulting in disability and death of millions of patients around the globe. We focus our groundbreaking science on identifying new medicines to preserve cognition and other brain functions and enhance resilience to neurodegenerative diseases. Our name reflects this focus: Muna means ‘to remember’ in Old Norse.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Muna Therapeutics?
Muna Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Muna Therapeutics last raise funding?
The most recent investment in Muna Therapeutics recorded on gritt.io was in July 2021.
When was Muna Therapeutics founded?
Muna Therapeutics was founded in 2020.
What industry is Muna Therapeutics in?
Muna Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Muna Therapeutics based?
Muna Therapeutics is headquartered in København N, Denmark.